Evidence map›Paper›PMID 25262416›Full record

ArticleNature chemical biology2014

Unraveling the mechanism of cell death induced by chemical fibrils.

Olivier Julien, Martin Kampmann, Michael C Bassik, Julie A Zorn, Vincent J Venditto, Kazutaka Shimbo, Nicholas J Agard, Kenichi Shimada, Arnold L Rheingold, Brent R Stockwell and 2 more

Abstract read
In one paragraph

Article in Nature chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Library Docking for Cannabinoid-2 Receptor Ligands.Journal of medicinal chemistry · 2026
    Article
  2. Article
  3. Synthesis, crystal structure and Hirshfeld surface analysis of 2-oxo-Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Sequence-independent recognition of the amyloid structural motif by GFP protein family.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. A new era for understanding amyloid structures and disease.Nature reviews. Molecular cell biology · 2018
    Review
  9. Article
  10. Article
  11. Allosteric sensitization of proapoptotic BAX.Nature chemical biology · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Phosphorylation at SerThe Journal of biological chemistry · 2017
    Article
  17. Article
  18. Crystal structures of three 6-substituted coumarin-3-carboxamide derivatives.Acta crystallographica. Section E, Crystallographic communications · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Olivier JulienDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.ORCID 0000000170687299
Martin Kampmann1] Department of Cellular and Molecular Pharmacology, University of California-San Francisco, San Francisco, California, USA. [2] Howard Hughes Medical Institute, University of California-San Francisco, San Francisco, California, USA.
Michael C BassikDepartment of Cellular and Molecular Pharmacology, University of California-San Francisco, San Francisco, California, USA.
Julie A ZornDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.
Vincent J VendittoDepartment of Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, California, USA.
Kazutaka ShimboDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.
Nicholas J AgardDepartment of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.
Kenichi ShimadaDepartment of Biological Sciences, Columbia University, New York, New York, USA.ORCID 0000000185409785
Arnold L RheingoldDepartment of Chemistry, University of California-San Diego, San Diego, California, USA.
Brent R Stockwell1] Department of Biological Sciences, Columbia University, New York, New York, USA. [2] Department of Chemistry, Columbia University, New York, New York, USA. [3] Howard Hughes Medical Institute, Columbia University, New York, New York, USA.
Jonathan S Weissman1] Department of Cellular and Molecular Pharmacology, University of California-San Francisco, San Francisco, California, USA. [2] Howard Hughes Medical Institute, University of California-San Francisco, San Francisco, California, USA.
James A Wells1] Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA. [2] Department of Cellular and Molecular Pharmacology, University of California-San Francisco, San Francisco, California, USA.

Funding

RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Chemical Genetic Profiling of Engineered Tumor CellsR01CA097061 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI STOCKWELL, BRENT R. · 2002 to 2016
$4.8M
Global Analysis of Proteolysis in ApoptosisR01GM081051 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WELLS, JAMES A · 2007 to 2015
$2.8M
Accelerating drug development and repurposing using systematic genetic interactioDP2HD084069 · NICHD · STANFORD UNIVERSITY · PI BASSIK, MICHAEL C · 2014 to 2014
$2.4M
Direct Chemical Activators of CaspasesR01CA136779 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WELLS, JAMES A · 2009 to 2013
$1.5M
Do peptide mimetics of gp41 improve antibody-epitope interactions?F32AI095062 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VENDITTO, VINCENT JOSEPH · 2012 to 2014
$163k
CIHRHoward Hughes Medical InstituteNCI NIH HHS R01 CA097061NCI NIH HHS R01 CA136779NIAID NIH HHS F32 AI095062NIAID NIH HHS F32AI095062NICHD NIH HHS DP2 HD084069NIGMS NIH HHS P41 GM103481NIGMS NIH HHS R01 GM081051NIGMS NIH HHS T32 GM064337
6 · The paper itself

Abstract

We previously discovered a small-molecule inducer of cell death, named 1541, that noncovalently self-assembles into chemical fibrils ('chemi-fibrils') and activates procaspase-3 in vitro. We report here that 1541-induced cell death is caused by the fibrillar rather than the soluble form of the drug. A short hairpin RNA screen reveals that knockdown of genes involved in endocytosis, vesicle trafficking and lysosomal acidification causes partial 1541 resistance. We confirm the role of these pathways using pharmacological inhibitors. Microscopy shows that the fluorescent chemi-fibrils accumulate in punctae inside cells that partially colocalize with lysosomes. Notably, the chemi-fibrils bind and induce liposome leakage in vitro, suggesting they may do the same in cells. The chemi-fibrils induce extensive proteolysis including caspase substrates, yet modulatory profiling reveals that chemi-fibrils form a distinct class from existing inducers of cell death. The chemi-fibrils share similarities with proteinaceous fibrils and may provide insight into their mechanism of cellular toxicity.

Indexed as

Amino Acid SequenceBenzamidesCaspase 3Cell DeathCell ProliferationCoumarinsDose-Response Relationship, DrugHumansK562 CellsLysosomesModels, BiologicalMolecular StructureStructure-Activity RelationshipTumor Cells, CulturedBenzamidesCaspase 3Coumarins

Identifiers

PMID25262416
PMCPMC4201873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.